Otsuka Holdings
4578.T
#618
Rank
$33.61 B
Marketcap
$62.20
Share price
-0.02%
Change (1 day)
73.11%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Revenue for Otsuka Holdings (4578.T)

Revenue in 2024 (TTM): $14.47 Billion USD

According to Otsuka Holdings 's latest financial reports the company's current revenue (TTM ) is $14.47 Billion USD. In 2023 the company made a revenue of $14.19 Billion USD an increase over the revenue in the year 2022 that were of $13.02 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Otsuka Holdings from 2010 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $14.47 B1.98%
2023 $14.19 B8.96%
2022 $13.02 B-2.61%
2021 $13.37 B-0.3%
2020 $13.41 B4.72%
2019 $12.81 B9.42%
2018 $11.70 B6.04%
2017 $11.04 B0.57%
2016 $10.98 B-8.28%
2015 $11.97 B
2013 $14.15 B-1.07%
2012 $14.30 B-0.08%
2011 $14.31 B12.25%
2010 $12.75 B